Abbott, Johnson & Johnson Market Share in Tubeless Insulin Pump Market|Key Players: Insulet Corporation, Medtrum Technologies Inc.

Advent of new technologies in continuous glucose monitoring without the need for daily insulin injection doses will stimulate business growth over the forecast years. Growing adoption of minimally invasive insulin delivery methods should improve patient compliance. Inadequate reimbursement coverage and high long-term cost associated with tubeless insulin pump will hamper its adoption in emerging economies. Compliance to insulin therapy may reduce owing to high maintenance therapy cost.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2032

The pods/patches tubeless insulin pump market should witness more than 20% CAGR over the coming years. Regular replacement of pods and high usage frequency will drive the escalated demand for these products. Tubeless insulin pump remote should grow in parallel with the pods segment. Although the replacement rate of remotes is not as high as that of pods, their initial capital requirement is higher. Increasing sales of new tubeless insulin pump will fuel the significant growth of the remote market.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Cellnovo Group SA
• Valeritas
• Spring Health
• Debiotech SA
• CeQur
• Abbott
• Johnson & Johnson
• Insulet Corporation
• Medtrum Technologies Inc.

E-commerce held the largest market share in 2016 and will continue to be the biggest distribution channel for tubeless insulin pump over the forecast period. Its popularity should grow over coming years owing to rapid penetration of internet and ease of procurement from remote locations, the e-commerce will be the most popular channel for purchase of tubeless insulin pump. Hospitals has been the most popular distribution channel for insulin delivery and diabetic patient care. Many hospitals have started offering tubeless insulin pump to in-patient as well as out-patients stimulating the business growth over the forecast years.

Escalating prevalence of diabetes and obesity, growing geriatric population and technological advances in tubeless insulin delivery should drive the market size. According to WHO, diabetes will be the among the leading causes of death by 2030. These factors will prominently intensify the global usage of tubeless insulin pump over the forecast period.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2032

U.S. tubeless insulin pump market valued over USD 200 million in 2016 and anticipated to grow significantly over the coming years. Switching of insulin pump user from tubed to tubeless should be the major growth rendering factor. Moreover, increasing adoption of tubeless pump by first time users will fuel regional industry growth.

Tubeless insulin Pump market by component
o Pod/Patch
o Remote

Tubeless insulin Pump market by distribution channel
o Hospitals
o Pharmacies
o E-commerce

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.